IRIS Archives

Information and Referral and Internet Sightings

IRIS@LISTSERV.ICORS.ORG

Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
Sylvia Caras <[log in to unmask]>
Reply To:
Date:
Wed, 24 Mar 2010 10:59:29 -0700
Content-Type:
text/plain
Parts/Attachments:
text/plain (23 lines)
 From Maxine:

"Psychiatric journals report slightly higher rates of industry 
funding of published studies than other medical journals. And one 
study found that 90% of the advisers who help write American 
Psychiatric Association guidelines had undisclosed financial ties to 
industry, Insel writes in JAMA.

Meanwhile, antidepressants and other drug treatments rack up 
multibillion-dollar annual sales while non-drug treatments such as 
therapy are "woefully underused," Insel writes."

Dr. Thomas Insel is head of the National Institute of Mental Health.

<http://www.usatoday.com/news/health/2010-03-23-psychiatrists-drug-companies_N.htm>http://www.usatoday.com/news/health/2010-03-23-psychiatrists-drug-companies_N.htm 


Here's the JAMA citation - I don't have access
<http://jama.ama-assn.org/cgi/content/extract/303/12/1192>http://jama.ama-assn.org/cgi/content/extract/303/12/1192 


www.peoplewho.org

ATOM RSS1 RSS2